Cronos Group Inc

Most Recent

  • uploads///Canopy Growths Cost Gram
    Company & Industry Overviews

    Why Canopy Growth’s BC Cannabis Cultivation License Is a Big Deal

    On February 20, 2018, Canopy Growth (WEED) announced that it had received a cultivation license for one of its two sites at Aldergrove, British Columbia, under its BC Tweed Joint Venture.

    By Adam Jones
  • uploads///Inventory Biological Assets
    Earnings Report

    How Canopy Growth Is Preparing for Legalized Cannabis

    During 3Q18, Canopy Growth increased its inventory and biological assets to a value of 108.3 Canadian dollars from 56 million Canadian dollars in 3Q17.

    By Adam Jones
  • uploads///Next  Year Sales Revision
    Miscellaneous

    How Analysts’ Estimates for Cannabis Companies Have Evolved

    Earlier, we were left with the question of whether the valuations of cannabis stocks had been stretched. To answer that question, we’ll have to look at what was priced in to their valuation multiples.

    By Adam Jones
  • uploads///Filing Requirements
    Company & Industry Overviews

    What Cronos Group’s Listing on the NASDAQ Global Market Means

    With the elevation of its listing to the NASDAQ Global Market from the NASDAQ International Designation program, Cronos Group’s (PRMCF) management believes…

    By Adam Jones
  • uploads///mmj _
    Company & Industry Overviews

    Why Cannabis Stock Cronos Group Surged 11% Yesterday

    On February 26, cannabis company (HMMJ) Cronos Group (MJN)(PRMCF) surged almost 10.8%.

    By Adam Jones
  • uploads///Cannabis Stock Returns For the week Ending February
    Consumer

    A Review of the Biggest Losers in the Cannabis Sector Last Week

    With the increased perception of market risk, it’s natural that cannabis-related stocks also experienced a sell-off last week. Let’s look at this in more detail.

    By Adam Jones
  • uploads///Market Reach
    Miscellaneous

    Aurora Cannabis’s Reach and the CanniMed Acquisition

    In our series Must-Knows before Investing in the Marijuana Industry, we saw how, globally, the acceptance of marijuana has evolved, with more countries either legalizing cannabis access at a federal level or exploring the possibility of legalizing cannabis.

    By Adam Jones
  • uploads///Marijuana ETF Performance
    Consumer

    How Wall Street Is Taking an Interest in the Marijuana Industry

    Marijuana is still classified as a Schedule 1 drug in the United States and is illicit under federal law. This has created several issues for businesses.

    By Adam Jones
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.